TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research and Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research and Development
Curated by ChEMBL
Affinity DataKi: <1.00E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair